Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

4.75
Delayed Data
As of 11:36am ET
 0.00 / 0.00%
Today’s Change
3.30
Today|||52-Week Range
6.90
-12.84%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close4.75
Today’s open4.70
Day’s range4.65 - 4.80
Volume2,902
Average volume (3 months)117,101
Market cap$133.6M
Dividend yield--
Data as of 11:36am ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)-42.42%
Earnings growth (this year)+39.15%
Earnings growth (next 5 years)--
Revenue growth (last year)+98.84%
P/E ratioNM
Price/Sales14.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVLNNovelion Therapeutic...-0.04-0.47%
CDXCChromadex Corp-0.13-3.96%
CDTXCidara Therapeutics ...-0.32-4.68%
NATRNatures Sunshine Pro...-0.02-0.19%
Data as of 11:44am ET, 08/21/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$9.5M
Annual profit (last year)-$11.9M
Net profit margin-125.31%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent J. Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts